Infosys Limited (INFY) Receives a Hold from Citi
Confident Investing Starts Here:
Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Goyal covers the Technology sector, focusing on stocks such as LTIMindtree Limited, Tech Mahindra Limited, and HCL Technologies Limited. According to TipRanks, Goyal has an average return of 0.7% and a 60.00% success rate on recommended stocks.
Infosys Limited has an analyst consensus of Moderate Buy, with a price target consensus of INR1,845.06, a 14.74% upside from current levels. In a report released on June 18, Morgan Stanley also maintained a Hold rating on the stock with a INR1,670.00 price target.
The company has a one-year high of INR2,006.80 and a one-year low of INR1,307.10. Currently, Infosys Limited has an average volume of 368.5K.
Based on the recent corporate insider activity of 94 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of INFY in relation to earlier this year.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
4 hours ago
- Yahoo
Citi Raises PT on Pfizer Inc. (PFE) to $26; Maintains ‘Neutral' Rating
With strong hedge fund interest and a low price-to-earnings ratio, Pfizer Inc. (NYSE:PFE) secures a place on our list of the . A closeup shot of a laboratory technician handling a medical device used for fertility treatments. Following the company's strong Q2 performance, Citi raised its price target on Pfizer Inc. (NYSE:PFE) from $25 to $26 on August 6, 2025, maintaining a 'Neutral' rating. The analyst attributed the target revision to strong results. At the same time, Citi advised caution regarding continued policy uncertainties. Pfizer Inc. (NYSE:PFE) reported 10% revenue growth, taking total revenue to $14.7 billion. The top-line growth was driven by strong sales of the Vyndaqel product family, Comirnaty, Paxlovid, Padcev, Eliquis, and other products. At the quarter-end, the company also reiterated its 2025 revenue guidance of $61.0-$64.0 billion, while raising its adjusted diluted EPS outlook by $0.10 at the midpoint to $2.90-$3.10. This guidance raise was made despite challenges caused by the Inflation Reduction Act's Medicare Part D redesign. Pfizer Inc. (NYSE:PFE) discovers, develops, and markets biopharmaceutical products globally. It is included in our list of the most undervalued value stocks to buy. While we acknowledge the potential of PFE as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and . Disclosure: None.
Business Insider
4 hours ago
- Business Insider
Kepler Capital Reaffirms Their Buy Rating on FM Mattsson Mora Group AB Class B (1FS0)
In a report released on August 15, Mats Liss from Kepler Capital maintained a Buy rating on FM Mattsson Mora Group AB Class B, with a price target of SEK64.00. The company's shares closed last Thursday at €5.14. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Liss covers the Industrials sector, focusing on stocks such as Volvo AB, Munters Group AB, and Indutrade AB. According to TipRanks, Liss has an average return of 2.2% and a 53.21% success rate on recommended stocks. Currently, the analyst consensus on FM Mattsson Mora Group AB Class B is a Moderate Buy with an average price target of €5.78, a 12.45% upside from current levels. In a report released yesterday, TR | OpenAI – 4o also reiterated a Buy rating on the stock with a SEK65.00 price target.
Business Insider
4 hours ago
- Business Insider
Hapag Lloyd (0RCG) Receives a Sell from Kepler Capital
In a report released on August 15, Axel Styrman from Kepler Capital maintained a Sell rating on Hapag Lloyd, with a price target of €123.00. The company's shares closed last Friday at €119.60. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Styrman covers the Energy sector, focusing on stocks such as Frontline, Euronav, and Torm. According to TipRanks, Styrman has an average return of -5.5% and a 37.50% success rate on recommended stocks. In addition to Kepler Capital , Hapag Lloyd also received a Sell from UBS's Cristian Nedelcu in a report issued on August 15. However, yesterday, TR | OpenAI – 4o reiterated a Buy rating on Hapag Lloyd (LSE: 0RCG). Based on Hapag Lloyd's latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of €5.05 billion and a net profit of €441.7 million. In comparison, last year the company earned a revenue of €4.26 billion and had a net profit of €294.7 million
